Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge

Abstract Since 2013, the outbreak or sporadic infection of a new reassortant H7N9 influenza virus in China has resulted in hundreds of deaths and thousands of illnesses. An H7N9 vaccine is urgently needed, as a licensed human vaccine against H7N9 influenza is currently not available. Here, we develo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiang Wang, Weihui Fu, Songhua Yuan, Xi Yang, Yufeng Song, Lulu Liu, Yudan Chi, Tao Cheng, Man Xing, Yan Zhang, Chao Zhang, Yong Yang, Caihong Zhu, Xiaoyan Zhang, Sidong Xiong, Jianqing Xu, Dongming Zhou
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/01fc40478339433a96e030a84ab2587f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:01fc40478339433a96e030a84ab2587f
record_format dspace
spelling oai:doaj.org-article:01fc40478339433a96e030a84ab2587f2021-12-02T12:32:46ZBoth haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge10.1038/s41598-017-02019-12045-2322https://doaj.org/article/01fc40478339433a96e030a84ab2587f2017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-02019-1https://doaj.org/toc/2045-2322Abstract Since 2013, the outbreak or sporadic infection of a new reassortant H7N9 influenza virus in China has resulted in hundreds of deaths and thousands of illnesses. An H7N9 vaccine is urgently needed, as a licensed human vaccine against H7N9 influenza is currently not available. Here, we developed a recombinant adenovirus-based vaccine, AdC68-H7HA, by cloning the H7N9 haemagglutinin (HA) gene into the chimpanzee adenoviral vector AdC68. The efficacy of AdC68-H7HA was evaluated in mice as well as guinea pigs. For comparison, an H7N9 DNA vaccine based on HA was also generated and tested in mice and guinea pigs. The results demonstrated that both AdC68-H7HA and the DNA vaccine prime-adenovirus boost regimen induced potent immune responses in animals and completely protected mice from lethal H7N9 influenza viral challenge. A post-immunization serum transfer experiment showed that antibody responses could completely protect against lethal challenge, while a T cell depletion experiment indicated that HA-specific CD8+ T cells responses also contributed to protection. Therefore, both HA-specific humoral immunity and cellular immunity play important roles in the protection. These data suggest that the chimpanzee adenovirus expressing HA is a promising vaccine candidate for H7N9 virus or other influenza viral subtypes.Xiang WangWeihui FuSonghua YuanXi YangYufeng SongLulu LiuYudan ChiTao ChengMan XingYan ZhangChao ZhangYong YangCaihong ZhuXiaoyan ZhangSidong XiongJianqing XuDongming ZhouNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Xiang Wang
Weihui Fu
Songhua Yuan
Xi Yang
Yufeng Song
Lulu Liu
Yudan Chi
Tao Cheng
Man Xing
Yan Zhang
Chao Zhang
Yong Yang
Caihong Zhu
Xiaoyan Zhang
Sidong Xiong
Jianqing Xu
Dongming Zhou
Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge
description Abstract Since 2013, the outbreak or sporadic infection of a new reassortant H7N9 influenza virus in China has resulted in hundreds of deaths and thousands of illnesses. An H7N9 vaccine is urgently needed, as a licensed human vaccine against H7N9 influenza is currently not available. Here, we developed a recombinant adenovirus-based vaccine, AdC68-H7HA, by cloning the H7N9 haemagglutinin (HA) gene into the chimpanzee adenoviral vector AdC68. The efficacy of AdC68-H7HA was evaluated in mice as well as guinea pigs. For comparison, an H7N9 DNA vaccine based on HA was also generated and tested in mice and guinea pigs. The results demonstrated that both AdC68-H7HA and the DNA vaccine prime-adenovirus boost regimen induced potent immune responses in animals and completely protected mice from lethal H7N9 influenza viral challenge. A post-immunization serum transfer experiment showed that antibody responses could completely protect against lethal challenge, while a T cell depletion experiment indicated that HA-specific CD8+ T cells responses also contributed to protection. Therefore, both HA-specific humoral immunity and cellular immunity play important roles in the protection. These data suggest that the chimpanzee adenovirus expressing HA is a promising vaccine candidate for H7N9 virus or other influenza viral subtypes.
format article
author Xiang Wang
Weihui Fu
Songhua Yuan
Xi Yang
Yufeng Song
Lulu Liu
Yudan Chi
Tao Cheng
Man Xing
Yan Zhang
Chao Zhang
Yong Yang
Caihong Zhu
Xiaoyan Zhang
Sidong Xiong
Jianqing Xu
Dongming Zhou
author_facet Xiang Wang
Weihui Fu
Songhua Yuan
Xi Yang
Yufeng Song
Lulu Liu
Yudan Chi
Tao Cheng
Man Xing
Yan Zhang
Chao Zhang
Yong Yang
Caihong Zhu
Xiaoyan Zhang
Sidong Xiong
Jianqing Xu
Dongming Zhou
author_sort Xiang Wang
title Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge
title_short Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge
title_full Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge
title_fullStr Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge
title_full_unstemmed Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge
title_sort both haemagglutinin-specific antibody and t cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza h7n9 viral challenge
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/01fc40478339433a96e030a84ab2587f
work_keys_str_mv AT xiangwang bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT weihuifu bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT songhuayuan bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT xiyang bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT yufengsong bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT lululiu bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT yudanchi bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT taocheng bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT manxing bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT yanzhang bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT chaozhang bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT yongyang bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT caihongzhu bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT xiaoyanzhang bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT sidongxiong bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT jianqingxu bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
AT dongmingzhou bothhaemagglutininspecificantibodyandtcellresponsesinducedbyachimpanzeeadenoviralvaccineconferprotectionagainstinfluenzah7n9viralchallenge
_version_ 1718393957402017792